Welcome to Technology Offer
 
Search
Welcome to Technology Offer
 
BIOMEDICAL SCIENCES
Category : BIOMEDICAL SCIENCES
As Singapore's new Biomedical Industry emerges, our biomedical technologies begin to span 'state of the art' key areas of Bioinformatics, Medical Imaging, Medical Devices, Molecular Biology, Genomic, and Proteomics, to positively maximize the impact to our economy.

Cross fertilisation of these biomedical technologies create new value-added opportunities for other established domains in Singapore such as the electro, mechanical and material sciences, where Singapore has a proven track record. These technology opportunities will be harnessed and exploited according to current strengths and to the best of our advantage. We expect to see an infusion of innovative biomedical technologies that ultimately create a vibrant and sustainable economy.

We begin by offering technologies that harness Singapore's internationally recognized strengths in bioinformatics, drug discovery and medical imaging.

 
Technology Offer
A method and apparatus for creating Medical Teaching Files
Methods and apparatus for processing medical images
A System, Method and Interface for Building Biological Databases
Control of Bacterial Infection by Quenching Bacterial Cell-Cell Signaling (Quorum Sensing)
DNA-Based Diagnosis of Malaria
More Technology Offer
Welcome to Technology Offer


Genome Institute of Singapore and Roche announce collaboration on development of SARS detection kit

May 22 2003 - Genome Institute of Singapore and Roche Diagnostics announced an agreement to co-develop a Severe Acute Respiratory Syndrome (SARS) detection kit based on one of Roche's platform technologies - Polymerase Chain Reaction (PCR) technology. SARS is a respiratory infection, caused by a new strain of coronavirus, that has recently been reported in a number of regions, including Singapore. Since its outbreak in March, the Genome Institute of Singapore has been working to sequence the genetic code of the SARS coronavirus and has defined its genetic diversity. This information is critical to the development of robust diagnostic assays.


The diagnostic kit is expected to be ready... Please click here for the full news release.

For archive news, Please click here for news release.

Useful Links

Welcome to Exploit Technologies Pte Ltd
 
Copyright 2002 Exploit Technologies Pte Ltd. All Right Reserved